| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/13/2023 | Replimune Group, Inc. | REPL | Sale | Common Stock | 817 | $23.45 | $19.2k | | 06/13/2023 |
| 06/13/2023 | Replimune Group, Inc. | REPL | Sale | Common Stock | 12k | $24.10 | $290.2k | | 06/13/2023 |
| 05/16/2023 | Replimune Group, Inc. | REPL | Sale | Common Stock | 12.2k | $18.05 | $220.3k | | 05/16/2023 |
| 04/01/2023 | Replimune Group, Inc. | REPL | Grant | Employee Stock Option (right to buy) | 60k | $17.66 | $1.1M | | 04/01/2023 |
| 04/01/2023 | Replimune Group, Inc. | REPL | Grant | Common Stock | 40k | $0.00 | $0 | | 04/01/2023 |
| 03/01/2023 | DiaMedica Therapeutics Inc. | DMAC | Grant | Stock option (right to buy) | 26.4k | $1.77 | $46.8k | | 03/01/2023 |
| 05/16/2022 | Replimune Group, Inc. | REPL | Sale | Common Stock | 5.5k | $14.59 | $79.9k | | 05/16/2022 |
| 04/01/2022 | Replimune Group, Inc. | REPL | Grant | Employee Stock Option (right to buy) | 78.8k | $18.26 | $1.4M | | 04/01/2022 |
| 04/01/2022 | Replimune Group, Inc. | REPL | Grant | Common Stock | 52.5k | $0.00 | $0 | | 04/01/2022 |
| 05/10/2021 | Replimune Group, Inc. | REPL | Grant | Employee Stock Option (right to buy) | 110k | $33.99 | $3.7M | | 05/10/2021 |
| 05/10/2021 | Replimune Group, Inc. | REPL | Grant | Common Stock | 73.3k | $0.00 | $0 | | 05/10/2021 |
| 04/01/2021 | Replimune Group, Inc. | REPL | Grant | Stock Option (right to buy) | 16.5k | $31.58 | $521.1k | | 04/01/2021 |
| 02/25/2021 | Karyopharm Therapeutics Inc. | KPTI | Grant | Common Stock | 22k | $0.00 | $0 | | 02/25/2021 |
| 02/25/2021 | Karyopharm Therapeutics Inc. | KPTI | Grant | Stock Option (right to buy) | 60k | $14.56 | $873.1k | | 02/25/2021 |
| 02/11/2021 | Karyopharm Therapeutics Inc. | KPTI | Sale | Common Stock | 2k | $15.52 | $31.8k | | 02/11/2021 |
| 02/05/2021 | Karyopharm Therapeutics Inc. | KPTI | Exercise | Restricted Stock Units | 5.6k | $0.00 | $0 | | 02/05/2021 |
| 11/02/2020 | Replimune Group, Inc. | REPL | Grant | Stock Option (right to buy) | 33k | $42.00 | $1.4M | | 11/02/2020 |
| 10/30/2020 | Karyopharm Therapeutics Inc. | KPTI | Sale | Common Stock | 226 | $15.58 | $3.5k | | 10/28/2020 |
| 10/28/2020 | Karyopharm Therapeutics Inc. | KPTI | Exercise | Restricted Stock Units | 765 | $0.00 | $0 | | 10/28/2020 |
| 02/05/2020 | Karyopharm Therapeutics Inc. | KPTI | Grant | Restricted Stock Units | 22.6k | $0.00 | $0 | | 02/05/2020 |
| 02/05/2020 | Karyopharm Therapeutics Inc. | KPTI | Grant | Stock Option (right to buy) | 60.6k | $18.00 | $1.1M | | 02/05/2020 |
| 12/10/2008 | VION PHARMACEUTICALS INC | VION | Grant | Common Stock | 20k | $0.00 | $0 | | 12/10/2008 |